-
1
-
-
0034958947
-
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care
-
Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29: 1303-10.
-
(2001)
Crit Care Med
, vol.29
, pp. 1303-1310
-
-
Angus, D.C.1
Linde-Zwirble, W.T.2
Lidicker, J.3
-
2
-
-
31344461826
-
Sepsis in European intensive care units: results of the soap study
-
Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the soap study. Crit Care Med. 2006;34: 344-53.
-
(2006)
Crit Care Med
, vol.34
, pp. 344-353
-
-
Vincent, J.L.1
Sakr, Y.2
Sprung, C.L.3
-
3
-
-
72249087115
-
International study of the prevalence and outcomes of infection in intensive care units
-
Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302: 2323-9.
-
(2009)
Jama
, vol.302
, pp. 2323-2329
-
-
Vincent, J.L.1
Rello, J.2
Marshall, J.3
-
4
-
-
9644295892
-
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004
-
National Nosocomial Infections Surveillance System
-
National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32: 470-85.
-
(2004)
Am J Infect Control
, vol.32
, pp. 470-485
-
-
-
5
-
-
0141610906
-
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting
-
Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118: 146-55.
-
(2000)
Chest
, vol.118
, pp. 146-155
-
-
Ibrahim, E.H.1
Sherman, G.2
Ward, S.3
-
6
-
-
33744527833
-
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
-
Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34: 1589-96.
-
(2006)
Crit Care Med
, vol.34
, pp. 1589-1596
-
-
Kumar, A.1
Roberts, D.2
Wood, K.E.3
-
7
-
-
13644269309
-
-
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
-
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171: 388-416.
-
(2005)
Am J Respir Crit Care Med
, vol.171
, pp. 388-416
-
-
-
8
-
-
66949140382
-
Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America
-
Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49: 1-45.
-
(2009)
Clin Infect Dis
, vol.49
, pp. 1-45
-
-
Mermel, L.A.1
Allon, M.2
Bouza, E.3
-
9
-
-
73649114948
-
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
-
Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50: 133-64.
-
(2010)
Clin Infect Dis
, vol.50
, pp. 133-164
-
-
Solomkin, J.S.1
Mazuski, J.E.2
Bradley, J.S.3
-
10
-
-
84873339299
-
Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012
-
Dellinger RP, Levy MM, Rhodes A, et al. Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41: 580-637.
-
(2013)
Crit Care Med
, vol.41
, pp. 580-637
-
-
Dellinger, R.P.1
Levy, M.M.2
Rhodes, A.3
-
11
-
-
0028893025
-
The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study
-
Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995;273: 117-23.
-
(1995)
Jama
, vol.273
, pp. 117-123
-
-
Rangel-Frausto, M.S.1
Pittet, D.2
Costigan, M.3
Hwang, T.4
Davis, C.S.5
Wenzel, R.P.6
-
12
-
-
3142634845
-
Acute renal failure and sepsis
-
Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;351: 159-69.
-
(2004)
N Engl J Med
, vol.351
, pp. 159-169
-
-
Schrier, R.W.1
Wang, W.2
-
13
-
-
80054894544
-
Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT)
-
Piccinni P, Cruz DN, Gramaticopolo S, et al. Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT). Minerva Anestesiol. 2011;77: 1072-83.
-
(2011)
Minerva Anestesiol
, vol.77
, pp. 1072-1083
-
-
Piccinni, P.1
Cruz, D.N.2
Gramaticopolo, S.3
-
15
-
-
0025276983
-
Pharmacokinetics of amikacin during continuous veno-venous hemofiltration
-
Armendariz E, Chelluri L, Ptachcinski R. Pharmacokinetics of amikacin during continuous veno-venous hemofiltration. Crit Care Med. 1990;18: 675-6.
-
(1990)
Crit Care Med
, vol.18
, pp. 675-676
-
-
Armendariz, E.1
Chelluri, L.2
Ptachcinski, R.3
-
16
-
-
17644438105
-
Pharmacokinetics and clearance of ciprofloxacin and amikacin in continuous hemodialysis
-
Cotera A, Aguila R, Gaete L, Saffie A, Lorca E, Thambo S. Pharmacokinetics and clearance of ciprofloxacin and amikacin in continuous hemodialysis. Rev Med Chil. 1995;123: 742-8.
-
(1995)
Rev Med Chil
, vol.123
, pp. 742-748
-
-
Cotera, A.1
Aguila, R.2
Gaete, L.3
Saffie, A.4
Lorca, E.5
Thambo, S.6
-
17
-
-
0029901297
-
Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltration
-
Joos B, Schmidli M, Keusch G. Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltration. Nephrol Dial Transplant. 1996;11: 1582-5.
-
(1996)
Nephrol Dial Transplant
, vol.11
, pp. 1582-1585
-
-
Joos, B.1
Schmidli, M.2
Keusch, G.3
-
18
-
-
0025829461
-
Amikacin pharmacokinetics during continuous veno-venous hemofiltration
-
Robert R, Rochard E, Malin F, Bouquet S. Amikacin pharmacokinetics during continuous veno-venous hemofiltration. Crit Care Med. 1991;19: 588-9.
-
(1991)
Crit Care Med
, vol.19
, pp. 588-589
-
-
Robert, R.1
Rochard, E.2
Malin, F.3
Bouquet, S.4
-
19
-
-
79955482956
-
Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy
-
Taccone FS, de Backer D, Laterre PF, et al. Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy. Int J Antimicrob Agents. 2011;37: 531-5.
-
(2011)
Int J Antimicrob Agents
, vol.37
, pp. 531-535
-
-
Taccone, F.S.1
de Backer, D.2
Laterre, P.F.3
-
20
-
-
80052848301
-
Once-daily amikacin dosing in burn patients treated with continuous venovenous hemofiltration
-
Akers KS, Cota JM, Frei CR, et al. Once-daily amikacin dosing in burn patients treated with continuous venovenous hemofiltration. Antimicrob Agents Chemother. 2011;55: 4639-42.
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 4639-4642
-
-
Akers, K.S.1
Cota, J.M.2
Frei, C.R.3
-
21
-
-
84878078549
-
An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration
-
D'Arcy DM, Casey E, Gowing CM, Donnelly MB, Corrigan OI. An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration. BMC Pharmacol Toxicol. 2012;13: 14.
-
(2012)
BMC Pharmacol Toxicol
, vol.13
, pp. 14
-
-
D'Arcy, D.M.1
Casey, E.2
Gowing, C.M.3
Donnelly, M.B.4
Corrigan, O.I.5
-
22
-
-
81555206668
-
Proposal of a pharmacokinetically optimized dosage regimen of antibiotics in patients receiving continuous hemodiafiltration
-
Yamamoto T, Yasuno N, Katada S, et al. Proposal of a pharmacokinetically optimized dosage regimen of antibiotics in patients receiving continuous hemodiafiltration. Antimicrob Agents Chemother. 2011;55: 5804-12.
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 5804-5812
-
-
Yamamoto, T.1
Yasuno, N.2
Katada, S.3
-
23
-
-
33644855939
-
Practice patterns in the management of acute renal failure in the critically ill patient: an international survey
-
Ricci Z, Ronco C, D'Amico G, et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant. 2006;21: 690-6.
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 690-696
-
-
Ricci, Z.1
Ronco, C.2
D'Amico, G.3
-
24
-
-
84856139754
-
Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the tigecycline evaluation and surveillance trial
-
Bertrand X, Dowzicky MJ. Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the tigecycline evaluation and surveillance trial. Clin Ther. 2012;34: 124-37.
-
(2012)
Clin Ther
, vol.34
, pp. 124-137
-
-
Bertrand, X.1
Dowzicky, M.J.2
-
25
-
-
77950524429
-
Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock
-
Taccone FS, Laterre PF, Spapen H, et al. Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock. Crit Care. 2010;14: R53.
-
(2010)
Crit Care
, vol.14
-
-
Taccone, F.S.1
Laterre, P.F.2
Spapen, H.3
-
26
-
-
0022388227
-
Drug removal during continuous arteriovenous hemofiltration: theory and clinical observations
-
Golper TA, Wedel SK, Kaplan AA, et al. Drug removal during continuous arteriovenous hemofiltration: theory and clinical observations. Int J Artif Organs. 1985;8: 307-12.
-
(1985)
Int J Artif Organs
, vol.8
, pp. 307-312
-
-
Golper, T.A.1
Wedel, S.K.2
Kaplan, A.A.3
-
27
-
-
0030813577
-
Clearance of ceftriaxone during haemodialysis using cuprophane, haemophane and polysulfone dialysers
-
Gabutti L, Taminelli-Beltraminelli L, Marone C. Clearance of ceftriaxone during haemodialysis using cuprophane, haemophane and polysulfone dialysers. Eur J Clin Pharmacol. 1997;53: 123-6.
-
(1997)
Eur J Clin Pharmacol
, vol.53
, pp. 123-126
-
-
Gabutti, L.1
Taminelli-Beltraminelli, L.2
Marone, C.3
-
28
-
-
0024405842
-
Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzers
-
Lanese DM, Alfrey PS, Molitoris BA. Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzers. Kidney Int. 1989;35: 1409-12.
-
(1989)
Kidney Int
, vol.35
, pp. 1409-1412
-
-
Lanese, D.M.1
Alfrey, P.S.2
Molitoris, B.A.3
-
29
-
-
0033828257
-
Influence of dialysis procedure, membrane surface and membrane material on iopromide elimination in patients with reduced kidney function
-
Matzkies FK, Reinecke H, Tombach B, et al. Influence of dialysis procedure, membrane surface and membrane material on iopromide elimination in patients with reduced kidney function. Am J Nephrol. 2000;20: 300-4.
-
(2000)
Am J Nephrol
, vol.20
, pp. 300-304
-
-
Matzkies, F.K.1
Reinecke, H.2
Tombach, B.3
-
30
-
-
0031784208
-
Ofloxacin clearance during hemodialysis: a comparison of polysulfone and cellulose acetate hemodialyzers
-
Thalhammer F, Kletzmayr J, El Menyawi I, et al. Ofloxacin clearance during hemodialysis: a comparison of polysulfone and cellulose acetate hemodialyzers. Am J Kidney Dis. 1998;32: 642-5.
-
(1998)
Am J Kidney Dis
, vol.32
, pp. 642-645
-
-
Thalhammer, F.1
Kletzmayr, J.2
El Menyawi, I.3
-
31
-
-
0026299952
-
Tobramycin clearance during simulated continuous arteriovenous hemodialysis
-
Cigarran-Guldris S, Brier ME, Golper TA. Tobramycin clearance during simulated continuous arteriovenous hemodialysis. Contrib Nephrol. 1991;93: 120-3.
-
(1991)
Contrib Nephrol
, vol.93
, pp. 120-123
-
-
Cigarran-Guldris, S.1
Brier, M.E.2
Golper, T.A.3
-
32
-
-
0023378458
-
Aminoglycoside binding to polyacrylonitrile hemofilter membranes during continuous hemofiltration
-
Kronfol NO, Lau AH, Barakat MM. Aminoglycoside binding to polyacrylonitrile hemofilter membranes during continuous hemofiltration. ASAIO Trans. 1987;33: 300-3.
-
(1987)
ASAIO Trans.
, vol.33
, pp. 300-303
-
-
Kronfol, N.O.1
Lau, A.H.2
Barakat, M.M.3
-
33
-
-
40549103791
-
Adsorption of amikacin, a significant mechanism of elimination by hemofiltration
-
Tian Q, Gomersall CD, Ip M, et al. Adsorption of amikacin, a significant mechanism of elimination by hemofiltration. Antimicrob Agents Chemother. 2008;52: 1009-13.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 1009-1013
-
-
Tian, Q.1
Gomersall, C.D.2
Ip, M.3
|